Mohr P - Search Results

1

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.

Livingstone E, Zimmer L, Hassel JC, Fluck M, Eigentler TK, Loquai C, Haferkamp S, Gutzmer R, Meier F, Mohr P, Hauschild A, Schilling B, Menzer C, Kiecker F, Dippel E, Roesch A, Ziemer M, Conrad B, Körner S, Windemuth-Kieselbach C, Schwarz L, Garbe C, Becker JC, Schadendorf D; Dermatologic Cooperative Oncology Group. Livingstone E, et al. Among authors: mohr p. Lancet. 2022 Oct 1;400(10358):1117-1129. doi: 10.1016/S0140-6736(22)01654-3. Epub 2022 Sep 10. Lancet. 2022. PMID: 36099927 Clinical Trial.

2

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma.

O'Day S, Pavlick A, Loquai C, Lawson D, Gutzmer R, Richards J, Schadendorf D, Thompson JA, Gonzalez R, Trefzer U, Mohr P, Ottensmeier C, Chao D, Zhong B, de Boer CJ, Uhlar C, Marshall D, Gore ME, Lang Z, Hait W, Ho P; CNTO 95 Investigators. O'Day S, et al. Among authors: mohr p. Br J Cancer. 2011 Jul 26;105(3):346-52. doi: 10.1038/bjc.2011.183. Epub 2011 Jul 12. Br J Cancer. 2011. PMID: 21750555 Free PMC article. Clinical Trial.

3

Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases.

Pires da Silva I, Li I, Ugurel S, Serra-Bellver P, Andhale A, Burnette H, Aya F, Conway JW, Braden J, Carlino MS, Menzies AM, Weichenthal M, Mohr P, Gutzmer R, Arance AM, Johnson DB, Lorigan P, Schadendorf D, Lo SN, Long GV. Pires da Silva I, et al. Among authors: mohr p. Eur J Cancer. 2024 Jul;205:114101. doi: 10.1016/j.ejca.2024.114101. Epub 2024 May 7. Eur J Cancer. 2024. PMID: 38735161

4

Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.

Choy H, LaPorte K, Knill-Selby E, Mohr P, Shyr Y. Choy H, et al. Among authors: mohr p. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):90-6. Semin Radiat Oncol. 1999. PMID: 10210546 Clinical Trial.

5

Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.

Choy H, Shyr Y, Cmelak AJ, Mohr PJ, Johnson DH. Choy H, et al. Among authors: mohr pj. Cancer. 2000 Mar 15;88(6):1336-46. doi: 10.1002/(sici)1097-0142(20000315)88:6<1336::aid-cncr9>3.0.co;2-m. Cancer. 2000. PMID: 10717614

6

Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy.

Amorino GP, Mohr PJ, Hercules SK, Pyo H, Choy H. Amorino GP, et al. Among authors: mohr pj. Cancer Chemother Pharmacol. 2000;46(5):423-6. doi: 10.1007/s002800000169. Cancer Chemother Pharmacol. 2000. PMID: 11127948

7

Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.

Kowalzick L, Rogozinski T, Wimheuer R, Pilz J, Manske U, Scholz A, Fierlbeck G, Mohr P, Ochsendorf F, Wagner G, Gaus W, Brzoska J, Jablonska S. Kowalzick L, et al. Among authors: mohr p. Eur J Dermatol. 2002 Nov-Dec;12(6):558-61. Eur J Dermatol. 2002. PMID: 12459527 Clinical Trial.

8

National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists.

Cmelak AJ, Choy H, Shyr Y, Mohr P, Glantz MJ, Johnson DH. Cmelak AJ, et al. Among authors: mohr p. Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):157-62. doi: 10.1016/s0360-3016(98)00557-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10219809

9

Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer.

Amorino GP, Hercules SK, Mohr PJ, Pyo H, Choy H. Amorino GP, et al. Among authors: mohr pj. Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):503-9. doi: 10.1016/s0360-3016(00)00461-2. Int J Radiat Oncol Biol Phys. 2000. PMID: 10802379

10

Temporal trends in inpatient care use for adult mental disorders in Czechia: a nationwide register-based study from 1994 to 2015.

Potočár L, Winkler P, Mohr P, Formánek T. Potočár L, et al. Among authors: mohr p. Soc Psychiatry Psychiatr Epidemiol. 2024 May 31. doi: 10.1007/s00127-024-02691-5. Online ahead of print. Soc Psychiatry Psychiatr Epidemiol. 2024. PMID: 38819518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

573 results

Search Page